To access this element change to forms mode OFF
Grant Award View - GA30103
TARGETING RNA POLYMERASE I TO TREAT CANCER
GA ID:
GA30103
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2022
Value (AUD):
$1,165,028.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
TARGETING RNA POLYMERASE I TO TREAT CANCER
Purpose:
An elevated level of ribosomal RNA (rRNA) production supports the uncontrolled growth of cancer cells and as a result they become 'addicted' to abnormal levels of rRNA. Consequently, cancer cells become more sensitive to drugs that target rRNA production. This application explores the development and use of 2nd-generation inhibitors of the enzyme that synthesizes rRNA (Pol I) for the treatment of hematological and solid cancers.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1158726
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Australian National University
Recipient ABN:
52 234 063 906
Grant Recipient Location
Suburb:
Canberra City
Town/City:
Canberra City
Postcode:
2601
State/Territory:
ACT
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT
Postcode:
Country:
AUSTRALIA